Advertisement

Carvedilol Tablets

[10 May 2016]

Products Affected - Description

Carvedilol oral tablet, Glenmark
25 mg, 500 count (NDC 68462-0165-05)
 
Carvedilol oral tablet, Mylan
12.5 mg, 500 count (NDC 00378-3633-07)
 
Carvedilol oral tablet, Mylan Institutional
6.25 mg, unit-dose 25 count (NDC 51079-0930-19)
12.5 mg, unit-dose 25 count (NDC 51079-0931-19)
 
Carvedilol oral tablet, Sun Pharma
3.125 mg, 100 count (NDC 57664-0242-88)
3.125 mg, 500 count (NDC 57664-0242-13)
3.125 mg, 1000 count (NDC 57664-0242-18)
6.25 mg, 100 count (NDC 57664-0244-88)
6.25 mg, 500 count (NDC 57664-0244-13)
6.25 mg, 1000 count (NDC 57664-0244-18)
12.5 mg, 100 count (NDC 57664-0245-88)
12.5 mg, 500 count (NDC 57664-0245-13)
12.5 mg, 1000 count (NDC 57664-0245-18)
25 mg, 100 count (NDC 57664-0247-88)
25 mg, 500 count (NDC 57664-0247-13)
25 mg, 1000 count (NDC 57664-0247-18)

Reason for the Shortage

  • Glenmark cannot provide a reason for the shortage.
  • Mylan cannot provide a reason for the shortage.
  • Sun Pharma cannot provide availability information at this time.
  • Teva cannot provide a reason for the shortage.

Available Products

Coreg oral tablet, GlaxoSmithKline
3.125 mg, 100 count (NDC 00007-4139-20)
6.25 mg, 100 count (NDC 00007-4140-20)
12.5 mg, 100 count (NDC 00007-4141-20)
25 mg, 100 count (NDC 00007-4142-20)

Carvedilol oral tablet, Aurobindo
3.125 mg, 100 count (NDC 65862-0142-01)
3.125 mg, 500 count (NDC 65862-0142-05)
6.25 mg, 100 count (NDC 65862-0143-01)
6.25 mg, 500 count (NDC 65862-0143-05)
12.5 mg, 100 count (NDC 65862-0144-01)
12.5 mg, 500 count (NDC 65862-0144-05)
25 mg, 100 count (NDC 65862-0145-01)
25 mg, 500 count (NDC 65862-0145-05)
 
Carvedilol oral tablet, Glenmark
3.125 mg, 100 count (NDC 68462-0162-01)
3.125 mg, 500 count (NDC 68462-0162-05)
6.25 mg, 100 count (NDC 68462-0163-01)
6.25 mg, 500 count (NDC 68462-0163-05)
12.5 mg, 100 count (NDC 68462-0164-01)
12.5 mg, 500 count (NDC 68462-0164-05)
25 mg, 100 count (NDC 68462-0165-01)
 
Carvedilol oral tablet, Major
3.125 mg, unit-dose 100 count (NDC 00904-6300-61)
25 mg, unit-dose 100 count (NDC 00904-6303-61)
6.25 mg, unit-dose 100 count (NDC 00904-6301-61)
12.5 mg, unit-dose 100 count (NDC 00904-6302-61)
 
Carvedilol oral tablet, Mylan
3.125 mg, 100 count (NDC 00378-3631-01)
3.125 mg, 500 count (NDC 00378-3631-05)
6.25 mg, 100 count (NDC 00378-3632-01)
6.25 mg, 500 count (NDC 00378-3632-05)
12.5 mg, 100 count (NDC 00378-3633-01)
12.5 mg, 500 count (NDC 00378-3633-05)
25 mg, 100 count (NDC 00378-3634-01)
25 mg, 500 count (NDC 00378-3634-05)
 
Carvedilol oral tablet, Mylan Institutional
3.125 mg, unit-dose 25 count (NDC 51079-0771-19)
3.125 mg, unit-dose 100 count (NDC 51079-0771-20)
6.25 mg, unit-dose 100 count (NDC 51079-0930-20)
12.5 mg, unit-dose 100 count (NDC 51079-0931-20)
25 mg, unit-dose 100 count (NDC 51079-0932-20)
 
Carvedilol oral tablet, Sandoz
3.125 mg, 100 count (NDC 00781-5221-01)
6.25 mg, 100 count (NDC 00781-5222-01)
12.5 mg, 100 count (NDC 00781-5223-01)
25 mg, 100 count (NDC 00781-5224-01)
 
Carvedilol oral tablet, Solco Healthcare US
3.125 mg, 100 count (NDC 43547-0254-10)
3.125 mg, 500 count (NDC 43547-0254-50)
6.25 mg, 100 count (NDC 43547-0255-10)
6.25 mg, 500 count (NDC 43547-0255-50)
12.5 mg, 100 count (NDC 43547-0256-10)
12.5 mg, 500 count (NDC 43547-0256-50)
25 mg, 100 count (NDC 43547-0257-10)
25 mg, 500 count (NDC 43547-0257-50)
 
Carvedilol oral tablet, Teva
3.125 mg, 100 count (NDC 00093-0051-01)
3.125 mg, 500 count (NDC 00093-0051-05)
6.25 mg, 100 count (NDC 00093-0135-01)
6.25 mg, 500 count (NDC 00093-0135-05)
12.5 mg, 100 count (NDC 00093-7295-01)
12.5 mg, 500 count (NDC 00093-7295-05)
25 mg, 100 count (NDC 00093-7296-01)
25 mg, 500 count (NDC 00093-7296-05)
 
Carvedilol oral tablet, Zydus
3.125 mg, 100 count (NDC 68382-0092-01)
3.125 mg, 500 count (NDC 68382-0092-05)
6.25 mg, 100 count (NDC 68382-0093-01)
6.25 mg, 500 count (NDC 68382-0093-05)
12.5 mg, 100 count (NDC 68382-0094-01)
12.5 mg, 500 count (NDC 68382-0094-05)
25 mg, 100 count (NDC 68382-0095-01)
25 mg, 500 count (NDC 68382-0095-05)

Estimated Resupply Dates

  • Glenmark has carvedilol 25 mg tablets in 500 count on back order and the company estimates a release date of mid-May 2016.
  • Mylan has carvedilol 12.5 mg tablets in 500 count (NDC 00378-3633-07) on back order and the company cannot estimate a release date.
  • Mylan Institutional has 6.25 mg in 25 count unit-dose tablets on back order and the company estimates a release date of mid-May 2016. Carvedilol 12.5 mg in 25 count unit-dose tablets are available with short expiration dating (April 2017).
  • Sun had all carvedilol tablet presentations on back order and the company cannot estimate a release date.Sun Pharma cannot provide availability information at this time.

Related Shortages

Updated

May 10, April 28, February 16, 2016; December 11, October 29, September 30 and 17, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing